Association of aspirin use and hormone receptor status with breast cancer risk.
Publication
, Journal Article
Woloshin, S; Schwartz, LM
Published in: JAMA
September 22, 2004
Duke Scholars
Published In
JAMA
DOI
EISSN
1538-3598
Publication Date
September 22, 2004
Volume
292
Issue
12
Start / End Page
1426 / 1427
Location
United States
Related Subject Headings
- Risk
- Receptors, Progesterone
- Receptors, Estrogen
- Humans
- General & Internal Medicine
- Breast Neoplasms
- Aspirin
- Anticarcinogenic Agents
- Anti-Inflammatory Agents, Non-Steroidal
- 42 Health sciences
Citation
APA
Chicago
ICMJE
MLA
NLM
Woloshin, S., & Schwartz, L. M. (2004). Association of aspirin use and hormone receptor status with breast cancer risk. JAMA, 292(12), 1426–1427. https://doi.org/10.1001/jama.292.12.1426-b
Woloshin, Steven, and Lisa M. Schwartz. “Association of aspirin use and hormone receptor status with breast cancer risk.” JAMA 292, no. 12 (September 22, 2004): 1426–27. https://doi.org/10.1001/jama.292.12.1426-b.
Woloshin S, Schwartz LM. Association of aspirin use and hormone receptor status with breast cancer risk. JAMA. 2004 Sep 22;292(12):1426–7.
Woloshin, Steven, and Lisa M. Schwartz. “Association of aspirin use and hormone receptor status with breast cancer risk.” JAMA, vol. 292, no. 12, Sept. 2004, pp. 1426–27. Pubmed, doi:10.1001/jama.292.12.1426-b.
Woloshin S, Schwartz LM. Association of aspirin use and hormone receptor status with breast cancer risk. JAMA. 2004 Sep 22;292(12):1426–1427.
Published In
JAMA
DOI
EISSN
1538-3598
Publication Date
September 22, 2004
Volume
292
Issue
12
Start / End Page
1426 / 1427
Location
United States
Related Subject Headings
- Risk
- Receptors, Progesterone
- Receptors, Estrogen
- Humans
- General & Internal Medicine
- Breast Neoplasms
- Aspirin
- Anticarcinogenic Agents
- Anti-Inflammatory Agents, Non-Steroidal
- 42 Health sciences